TY - JOUR
T1 - “Inflammatory skin march” in atopic dermatitis and psoriasis
AU - Furue, Masutaka
AU - Kadono, Takafumi
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Background: Comorbidities of cardiovascular diseases (CVDs), metabolic syndrome and autoimmune diseases with systemic inflammation are recent topics in medicine. Inflammatory skin diseases such as atopic dermatitis and psoriasis are an active source of diverse proinflammatory cytokines and chemokines, which are readily detectable in the circulation and are likely to be involved in developing comorbidities. Evidence: Both atopic dermatitis and psoriasis are frequently comorbid with CVD, metabolic syndrome and autoimmune diseases, the consequence of which is called “inflammatory skin march”, “psoriatic march” or “march of psoriasis”. Conclusion: In this review, we summarize the epidemiological evidence and pathogenetic concepts regarding inflammatory skin march in atopic dermatitis and psoriasis.
AB - Background: Comorbidities of cardiovascular diseases (CVDs), metabolic syndrome and autoimmune diseases with systemic inflammation are recent topics in medicine. Inflammatory skin diseases such as atopic dermatitis and psoriasis are an active source of diverse proinflammatory cytokines and chemokines, which are readily detectable in the circulation and are likely to be involved in developing comorbidities. Evidence: Both atopic dermatitis and psoriasis are frequently comorbid with CVD, metabolic syndrome and autoimmune diseases, the consequence of which is called “inflammatory skin march”, “psoriatic march” or “march of psoriasis”. Conclusion: In this review, we summarize the epidemiological evidence and pathogenetic concepts regarding inflammatory skin march in atopic dermatitis and psoriasis.
UR - http://www.scopus.com/inward/record.url?scp=85020544687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020544687&partnerID=8YFLogxK
U2 - 10.1007/s00011-017-1065-z
DO - 10.1007/s00011-017-1065-z
M3 - Review article
C2 - 28620798
AN - SCOPUS:85020544687
VL - 66
SP - 833
EP - 842
JO - Inflammation Research
JF - Inflammation Research
SN - 1023-3830
IS - 10
ER -